Saturday, October 24, 2015 • 7 a.m. - 5 p.m.

The Westin La Paloma Resort & Spa
3800 E. Sunrise Drive
Tucson, Arizona

Who should attend?

Primary Care Physicians, Nurse Practitioners, Physician Assistants, RNs, RT(R)s and Allied Health Professionals. Register by Sept. 15 for Early-Bird Discount

Continuing Education Credit

THMEP is accredited by the Arizona Medical Association to provide continuing medical education for physicians.

THMEP designates this live activity for a maximum of 7.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

NPs: This program is approved for 6.5 contact hour(s) of continuing education (which includes 1.8 hours of pharmacology) by the American Association of Nurse Practitioners.  Program ID 1507316. This program was planned in accordance with AANP CE Standards and Policies.

RNs: Provider approved by the California Board of Registered Nursing, Provider No. 10161, Program Number 2015-987 for 8.0 contact hours.

ASRT: ASRT has approved this event for 7.5 Category A contact hours.

Click for a brochure of the TMC CardioVascular Symposium

  • Keynote: Experience with Over 300 Ruptured Abdominal Aortic Aneurysms: What Have We Learned? - Benjamin Ware Stranes, M.D., FACS, Professor and Chief, Division of Vascular Surgery, University of Washington School of Medicine; Chief of Vascular and Endovascular Surgery, Harborview Medical Center
  • Optimizing Lipid Management to Improve Cardiovascular Outcomes - Nicole Ciffone, MS, ANP-C, CLS, AACC
  • The Search for the Optimal Drug Delivery Device for Treating PAD - Miguel Montero, M.D.
  • Maximizing Outcomes with Minimally Invasive Cardiothoracic Surgery - Kushagra Katariya, M.D.
  • Minimally Invasive Methods for Atherosclerotic Plaque Removal: An Update - Luis R. Leon, M.D.
  • Managing Hypertension for Optimal Cardiovascular Health - Basel Skeif, M.D., FACC
  • Lunch
  • Keynote: Sleep, Dreams and the Heart - Rubin Naiman, Ph.D., Sleep and Dream Specialist and Clinical Assistant Professor of Medicine, University of Arizona Center for Integrative Medicine
  • From Foreskin to Hyperbaric Oxygen: What is your Problem Wound Asking For? - Layla C. Lucas, M.D.
  • Second Decade of Transcatheter Heart Valve Therapy - Present and Future - William J. Thomas, M.D.
  • Sleep Apnea and Post Op Management - Ives de Chazal, M.D.
  • Glycemic Control in the Inpatient Setting - Shubh Kaur, M.D.
  • Pharmacogenetics and Vascular Disease - John P. Pacanowski, M.D.
  • Special Guest Speaker:  Genomics and Sudden Cardiac Death, Tom Callis, Ph.D., Director of Clinical Genetics, Transgenomic, Inc., New Haven, Connecticut
  • Raffle Drawing, Closing Remarks and Thank You Reception

COURSE LEARNING OBJECTIVES: At the end of the course, participants will be able to:

  1. Improve patient compliance, communication, shared decision making, and lifestyle choices by applying knowledge of current cardiovascular techniques, treatments and research.
  2. Improve medical management strategies of cardiovascular patients through application of established and evolving biomedical, clinical, and cognate sciences.
  3. Integrate best research with clinical expertise and patient values for optimum care of cardiovascular patients.        


Eventbrite - SAVE THE DATE: TMC CardioVascular Symposium 2015

For more information, contact Kathy at (520) 324-2073 or
Symposium Directors:
Luis R. Leon, M.D.  •  Gulshan K. Sethi, M.D.
Symposium Planning Coordinators: 
Anita C. Bach, R.T. (R), MHA, Service Line Adminstrator for Cardiovascular and Imaging Services
Roxanne Lee, RN, BSN, Manager of Patient Care Services
Registration includes continental breakfast, lunch and thank-you reception.
Refunds: Written requests for cancellation must be received by Oct. 10, 2015. Registration fee (less a 10 percent handling fee) will be issued within 10 days of request. Registrations for no-shows or cancellations received less than two weeks prior to the program date may be forfeited.
Disclaimer: Course director(s), planning committee, speakers and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Speakers will also disclose any off-label and/or investigational use of pharmaceuticals or instruments discussed in their presentation. Disclosure of this information will be published in course materials so those participants in the activity may formulate their own judgments regarding the presentation.